康臣药业11月6日斥资150.09万港元回购10万股
CONSUN PHARMACONSUN PHARMA(HK:01681) Zhi Tong Cai Jing·2025-11-06 10:37

Core Viewpoint - 康臣药业 announced a share buyback plan, indicating confidence in its stock value and potential for future growth [1] Summary by Category Company Actions - 康臣药业 plans to repurchase 100,000 shares at a total cost of 1.5009 million HKD, with each share priced between 15 and 15.04 HKD [1]